Plain-English translation of NCT05076019 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing atorvastatin, a common cholesterol-lowering medication, to see if it can prevent a specific type of irregular heartbeat (called atrial fibrillation) that sometimes develops after aortic valve replacement surgery. Patients will take either the medication or a placebo (a dummy pill that looks identical) starting about a week before surgery and continuing for 30 days afterward. Researchers want to know whether this medication can reduce the risk of developing this heart rhythm problem during recovery.
Many patients develop an irregular heartbeat after heart valve surgery, which can be uncomfortable and sometimes dangerous. Doctors are looking for safe ways to prevent this complication, and early research suggests this medication might help protect the heart during the stressful period after surgery.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to take either the medication or a placebo pill once daily. You'll start taking your assigned pill about 7 to 14 days before your scheduled valve surgery and continue for 30 days after surgery. During your hospital stay and follow-up visits, your heart rhythm will be monitored carefully using heart monitors and ECGs to check whether you develop an irregular heartbeat. The research team will also review your medical records and any heart rhythm monitoring done up to 30 days after surgery.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Denmark